What substances does this Instanosis multiplex test strip detect?

The Instanosis Fentanyl, Xylazine, and Nitazene Test Strip is a multiplexed lateral flow assay designed to simultaneously screen for fentanyl, the adulterant xylazine, and emerging synthetic opioids in the nitazene class within a single, rapid test workflow.

What is the package size and configuration for this product?

This product configuration contains a Box of 25 or 100 individually wrapped test strips, making it highly portable and ideally suited for field harm reduction deployments, mobile public health outreach, and forensic toxicology screening.

Is this multiplex test strip cleared for medical or clinical diagnostic use?

No. This specific product is strictly designated for Forensic and Field Harm Reduction applications only. It is not cleared for in vitro diagnostic (IVD) use, emergency room clinical toxicology, or human patient monitoring.

Can health networks, forensic labs, and public agencies purchase this kit through contract distributors?

Yes. Procurement departments, harm reduction networks, and forensic laboratories can source these 25-strip kits via direct institutional purchase orders or through primary scientific contract distributors such as Avantor/VWR.

Instanosis 3-in-1 Fentanyl Xylazine Nitazene drug test strip packaging and kit

3-in-1 Fentanyl/Xylazine/Nitazene test strip, for forensic and harm reduction applications

The USA-made Instanosis 3-in-1 Test Strip simultaneously detects Fentanyl (2 ng/mL), Xylazine (10 ng/mL), and Nitazene (50 ng/mL) for forensic and harm reduction applications. This high-sensitivity assay requires only 1/10th the sample volume of market competitors, delivering rapid, highly accurate multi-drug screening.

size

Clear

SKU: FXN25

Category: Drug Test Strips, Forensics, Harm Reduction, Product

Order through Avantor/VWR: Box of 25

Fetanyl/Xylazine/Nitazene test strip, individually packed.

Technical Specifications & Key Data

Simultaneous 3-in-1 Detection: Identifies Fentanyl, Xylazine, and Nitazenes on a single testing strip
Analytical Detection Cut-offs: Fentanyl: 2 ng/mL, Xylazine: 10 ng/mL, Nitazene: 50 ng/mL
Micro-Sample Efficiency: Requires only 1/10th of the sample volume typically demanded by standard market alternatives, preserving precious forensic evidence or research samples
Simultaneous 3-in-1 Detection: Identifies Fentanyl, Xylazine, and Nitazenes on a single testing strip
Sensitivity & Specificity: Highly optimized antibody pairing ensures an extremely low rate of false positives and false negatives
Manufacturing Quality: Proudly Made in the U.S. under strict FDA QMSR quality control guidelines
Funding Credential: Product development was fully funded by the National Institutes of Health (NIH)

Primary Applications

Harm Reduction Initiatives: Providing public health organizations and community programs with highly sensitive field screening tools
Forensic Investigations: Assisting law enforcement, medical examiners, and crime laboratories in rapidly identifying illicit drug compositions
Laboratory Research: Offering academic and biotech diagnostic researchers a reliable screening method for cross-contamination studies

Ordering Options & Availability

Packaging Configurations: Available in boxes of 25 strips or 100 strips (each testing strip is individually packed for shelf-life protection and field deployment)
Distribution Channels: Available for purchase directly or via authorized scientific distribution channels, including Avantor / VWR (Box of 25)
One strip detecting 3 the most dangerous drugs
Extremely sensitive and highly specific
Only requires 1/10 amount of samples compared to other products
User-friendly

Frequently Asked Questions (FAQ)

Q1: What specific substances can the Instanosis 3-in-1 test strip detect?

A: The Instanosis 3-in-1 test strip simultaneously detects Fentanyl, Xylazine (an animal tranquilizer frequently found in illicit supplies), and Nitazenes (a powerful class of synthetic opioids), all on a single testing strip.
Q2: What are the exact detection thresholds (cut-off levels) for each drug?

A: The precise analytical detection thresholds are 2 ng/ml for fentanyl, 10 ng/ml for xylazine, and 50 ng/ml for nitazene. These ultra-low cut-off levels make it one of the most sensitive options on the market.
Q3: How much sample material is needed to run a test?

A: Because of high quality antibodies and advanced assay optimization, this product requires only 1/10th of the sample volume required by other standard market test strips, preserving your primary forensic or research samples.
Q4: Where is this product manufactured and how was it developed?

A: The Instanosis 3-in-1 test strip is proudly made in the United States. Its development was funded by the National Institutes of Health (NIH), ensuring rigorous design and reliability.
Q5: Can these test strips be purchased through major scientific distributors?

A: Yes. In addition to our direct storefront, you can order the Instanosis Box of 25 strips directly through Avantor/VWR using our verified listings.
Q6: Is this product intended for medical or clinical diagnostic use?

A: No. This product is specifically designed and labeled for forensic investigations, harm reduction initiatives, and laboratory research applications only.